APOE and Alzheimer disease: Interestingly, higher CSF sTREM2 levels also appear to mitigate the ApoE4-associated risk of cognitive decline and AD-related neurodegeneration, suggesting that sTREM2 may have broader implications in neurodegenerative disease risk [128].